Sonic Healthcare Agrees US$150 Million Acquisition of Pathology Watch
By Stuart Condie
SYDNEY--Sonic Healthcare acquired Utah-based medical-tech provider Pathology Watch for US$150 million in what the Australian company called a strategic move that would accelerate its transition to digital pathology services.
Sonic on Thursday said that it would fund the acquisition from existing cash reserves and debt. Pathology Watch is currently at the pre-profit stage, but Sonic expects attractive earnings-per-share and return-on-invested-capital accretion over coming years.
Sonic added that Pathology Watch's founders, management and staff of Pathology Watch will join the ASX-listed company's U.S. and global operations. The deal is expected to close in December 2023.
"The acquisition of Pathology Watch is an important and enormously exciting step in Sonic's transition to digital pathology and pathology AI and offers multiple avenues for value creation," Sonic Chief Executive Colin Goldschmidt said.
The transaction is not material, Sonic said.
Write to Stuart Condie at stuart.condie@wsj.com
(END) Dow Jones Newswires
November 15, 2023 17:42 ET (22:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom